No takes yet. Share an insight, caveat, or question.
Preclinical study reveals that resveratrol lowers cholesterol by activating CYP7A1 via LXRα pathways in obese mice, indicating a potential target for treating dyslipidemia.
Chen et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: